LifeMD, Inc.
LFMD- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0000948320
No open-market purchases or sales by LifeMD, Inc. insiders were filed in the last 90 days; 116 institutions reported holding it in 13F filings for Q2 2026, worth $89.3M in total; no superinvestor holds it.
Other share classesLFMDP
13F holders, Q1 2025
Institutional positions in LifeMD, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −2 vs. Q4 2024
- Shares held
- 16.5M
- +868.8K (+5.6%) vs. Q4 2024
- Total value
- $89.7M
- +$12.4M (+16.0%) vs. Q4 2024
- New holders
- 17
- 39 more added
- Sold out
- 19
- 32 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LFMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 116 | $89.3M |
| Q1 2026 | 102 | $64.4M |
| Q4 2025 | 104 | $64.6M |
| Q3 2025 | 114 | $139.0M |
| Q2 2025 | 129 | $326.1M |
| Q1 2025 | 103 | $89.7M |
| Q4 2024 | 106 | $79.3M |
| Q3 2024 | 101 | $89.9M |
| Q2 2024 | 105 | $111.7M |
| Q1 2024 | 88 | $150.3M |
| Q4 2023 | 84 | $103.2M |
| Q3 2023 | 62 | $55.5M |
| Q2 2023 | 52 | $25.1M |
| Q1 2023 | 43 | $9.65M |
| Q4 2022 | 45 | $13.3M |
| Q3 2022 | 40 | $10.5M |
| Q2 2022 | 40 | $11.3M |
| Q1 2022 | 45 | $18.2M |
| Q4 2021 | 53 | $23.1M |
| Q3 2021 | 69 | $54.8M |
| Q2 2021 | 63 | $79.7M |
| Q1 2021 | 50 | $74.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding LifeMD, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royce & Associates LP | 1,155,231 | $6.28M | 0.07% | +39,240+3.5% | Added |
| Vanguard Group Inc | 1,880,505 | $10.2M | 0.00% | +120,279+6.8% | Added |
| BlackRock, Inc. | 2,522,920 | $13.7M | 0.00% | −19,949−0.8% | Reduced |
| X-Square Capital, LLC | 0 | $0 | 0.00% | −74,229−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −62,500−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −37,138−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −34,891−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −32,722−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −24,247−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Thompson Davis & Co., Inc. | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −11,595−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,556−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −11,343−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −10,443−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,423−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,290−100.0% | Sold out |
| Measured Risk Portfolios, Inc. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −2,535−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −430−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |